Sanofi
- Country
- 🇫🇷France
- Ownership
- Public
- Employees
- 87.9K
- Market Cap
- $141.3B
- Website
- http://www.sanofi.com
- Introduction
Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescript...
Postmarketing Surveillance Study for Quadrivalent Influenza Vaccine (VaxigripTetra®) in Subjects Aged 6 to 35 Months
- Conditions
- First Posted Date
- 2023-04-27
- Last Posted Date
- 2023-04-27
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 682
- Registration Number
- NCT05832333
- Locations
- 🇰🇷
Site 006, Gyeongsangnam-do, Korea, Republic of
🇰🇷Site 010, Gyeongsangnam-do, Korea, Republic of
🇰🇷Site 002, Gwangju, Korea, Republic of
A Comparison of Extended Versus Conventional Duration of Enoxaparin Prophylaxis (i.e., Preventive Treatment) for Venous Thromboembolism (VTE, i.e., Blood Clots in the Veins) and Bleeding Event Risk in a Population With Acute Medical Illness
- Conditions
- First Posted Date
- 2023-04-19
- Last Posted Date
- 2024-10-30
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 14799
- Registration Number
- NCT05819112
- Locations
- 🇺🇸
Sanofi U.S., Bridgewater, New Jersey, United States
Comparison of the Risk of Venous Thromboembolism (i.e., Blood Clots in the Veins) and Bleeding Events in a Population of Obese Patients Receiving Higher-Dose or Extended-Duration Versus Conventional-Dose or Conventional-Duration of Prophylaxis (i.e., Preventive Treatment) With Enoxaparin
- Conditions
- First Posted Date
- 2023-04-19
- Last Posted Date
- 2024-10-29
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 21000
- Registration Number
- NCT05819125
- Locations
- 🇺🇸
Sanofi U.S., Bridgewater, New Jersey, United States
A Study to Assess the Effect of Erythromycin on the Test Medicine (SAR443820) When Given Orally as Tablets to Healthy Adult Male and Female Participants (Part A); and the Effect of Itraconazole on the Test Medicine (SAR443820) When Given Orally as Capsules to Healthy Adult Male Participants (Part B)
- Conditions
- Interventions
- First Posted Date
- 2023-04-04
- Last Posted Date
- 2023-04-04
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 16
- Registration Number
- NCT05797753
- Locations
- 🇺🇸
Nucleus Network-Site Number:8400001, Saint Paul, Minnesota, United States
A Study in Healthy Adult Male & Female Participants to Assess the Amount of the Study Medicine (SAR443820) Absorbed by the Body, When Given Orally in Fasted Condition as a Tablet Versus as a Capsule (Part 1) and When Given Orally as a Tablet in Fasted Condition Versus as a Tablet After Food (Part 2)
- Conditions
- Interventions
- First Posted Date
- 2023-04-04
- Last Posted Date
- 2023-04-04
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 18
- Registration Number
- NCT05797701
- Locations
- 🇺🇸
Prism Research-Site Number:8400001, Saint Paul, Minnesota, United States
Single & Multiple Ascending Dose Study of SAR443820 in Healthy Adult Participants
- Conditions
- Interventions
- First Posted Date
- 2023-04-03
- Last Posted Date
- 2023-04-03
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 84
- Registration Number
- NCT05795907
- Locations
- 🇺🇸
Prism Research-Site Number:8400001, Saint Paul, Minnesota, United States
A PK Comparability Study of Two Different Amlitelimab Drug Products in Healthy Participants
- First Posted Date
- 2023-04-03
- Last Posted Date
- 2023-05-30
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 32
- Registration Number
- NCT05796479
- Locations
- 🇺🇸
Clinical Pharmacology of Miami-Site Number: 8400001, Hialeah, Florida, United States
Cold Agglutinin Disease Real World Evidence Registry
- Conditions
- Interventions
- First Posted Date
- 2023-03-30
- Last Posted Date
- 2024-03-28
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 400
- Registration Number
- NCT05791708
- Locations
- 🇺🇸
Mission Hope Medical Oncology Site Number : 1241, Santa Maria, California, United States
🇺🇸Hematology Oncology Associates, PC Site Number : 1211, Medford, Oregon, United States
🇫🇷Investigational Site Number : 3211, CHALON SUR SAONE Cedex, France
Open Label, Long-term Study Evaluating Safety and Efficacy of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
- First Posted Date
- 2023-03-15
- Last Posted Date
- 2024-12-06
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 901
- Registration Number
- NCT05769777
- Locations
- 🇦🇷
Investigational Site Number : 0320022, Gral. Pico, La Pampa, Argentina
🇦🇷Investigational Site Number : 0320007, Rosario, Santa Fe, Argentina
🇦🇷Investigational Site Number : 0320008, Buenos Aires, Argentina
Avalglucosidase Alfa Pregnancy Study
- Conditions
- Interventions
- First Posted Date
- 2023-02-21
- Last Posted Date
- 2024-07-15
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 100
- Registration Number
- NCT05734521
- Locations
- 🇺🇸
Investigational site worldwide, Bridgewater, New Jersey, United States